About: Prosocial polio vaccination in Israel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prosocial polio vaccination in Israel Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prosocial polio vaccination in Israel
Creator	Pandey, Abhishek Bauch, Chris Galvani, Alison Wells, Chad Fitzpatrick, Meagan Huppert, Amit Singer, Burton Velan, Baruch
Source	Medline; PMC
abstract	Regions with insufficient vaccination have hindered worldwide poliomyelitis eradication, as they are vulnerable to sporadic outbreaks through reintroduction of the disease. Despite Israel’s having been declared polio-free in 1988, a routine sewage surveillance program detected polio in 2013. To curtail transmission, the Israel Ministry of Health launched a vaccine campaign to vaccinate children—who had only received the inactivated polio vaccine—with the oral polio vaccine (OPV). Determining the degree of prosocial motivation in vaccination behavior is challenging because vaccination typically provides direct benefits to the individual as well as indirect benefits to the community by curtailing transmission. However, the Israel OPV campaign provides a unique and excellent opportunity to quantify and model prosocial vaccination as its primary objective was to avert transmission. Using primary survey data and a game-theoretical model, we examine and quantify prosocial behavior during the OPV campaign. We found that the observed vaccination behavior in the Israeli OPV campaign is attributable to prosocial behavior and heterogeneous perceived risk of paralysis based on the individual’s comprehension of the prosocial nature of the campaign. We also found that the benefit of increasing comprehension of the prosocial nature of the campaign would be limited if even 24% of the population acts primarily from self-interest, as greater vaccination coverage provides no personal utility to them. Our results suggest that to improve coverage, communication efforts should also focus on alleviating perceived fears surrounding the vaccine.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.1073/pnas.1922746117
bibo:pmid	32457142
has license	cc-by
sha1sum (hex)	8ef63ee6f80ca463ebd94324ea759b9d3bd8b451
schema:url	https://doi.org/10.1073/pnas.1922746117
resource representing a document's title	Prosocial polio vaccination in Israel
has PubMed Central identifier	PMC7293608
has PubMed identifier	32457142
schema:publication	Proc Natl Acad Sci U S A
resource representing a document's body	covid:8ef63ee6f80ca463ebd94324ea759b9d3bd8b451#body_text
is schema:about of	named entity 'polio vaccination' named entity 'Israel' named entity 'OPV' named entity 'Secular Jewish' named entity '2.04' named entity 'prosocial behavior' named entity 'perceived efficacy' named entity 'uniform distribution' named entity 'Beta distribution' named entity 'disability' named entity '3.5' named entity 'prosociality' named entity 'Likert scale' named entity 'prosocial behavior' named entity 'mathematical model' named entity 'family member' named entity 'vaccination rates' named entity 'OPV' named entity 'vaccination' named entity 'vaccination' named entity 'reproductive number' named entity 'vaccination' named entity 'vaccination' named entity 'vaccinating' named entity 'vaccination' named entity 'probability' named entity 'vaccination' named entity 'vaccine' named entity 'VAPP' named entity 'gamma distribution' named entity 'National Institute for Health' named entity 'beta distribution' named entity 'reproductive number' named entity 'uniform distribution' named entity 'vaccination' named entity 'vaccination' named entity 'prosocial behavior' named entity 'vaccination' named entity 'infection' named entity 'vaccination' named entity 'dashed' named entity 'vaccination' named entity 'vaccinating' named entity 'probability' named entity 'vaccination' named entity 'relative risk' named entity 'paralytic polio' named entity 'vaccination' named entity 'vaccinating' named entity 'VAPP' named entity '95% CI' named entity 'pure strategy' named entity 'standard deviation' named entity '250,000' named entity 'levels of society' named entity 'Bedouins' named entity 'relative risk' named entity 'vaccination' named entity 'left column' named entity 'correlation' named entity 'herd immunity' named entity 'independent samples' named entity '95% CI' named entity 'OPV' named entity 'infection' named entity 'risk perception' named entity 'reproductive number' named entity 'infection' named entity 'vaccination' named entity 'confidence intervals' named entity 'prosociality' named entity 'disability' named entity 'vaccination' named entity 'vaccination'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software